Phosphorylated LASS2 inhibits prostate carcinogenesis via negative regulation of Wnt/β‐catenin signaling
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.29926
Abstract: LASS2 is a novel tumor‐suppressor gene and has been characterized as a ceramide synthase, which synthesizes very‐long acyl chain ceramides. However, LASS2 function and pathway‐related activity in prostate carcinogenesis are still largely unexplored. Here, we… read more here.
Keywords: inhibits prostate; phosphorylated lass2; catenin; prostate carcinogenesis ... See more keywords
Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction
Sign Up to like & getrecommendations! Published in 2019 at "Cell Proliferation"
DOI: 10.1111/cpr.12718
Abstract: We investigated the anti‐cancer activity of pentamidine, an anti‐protozoal cationic aromatic diamidine drug, in prostate cancer cells and aimed to provide valuable insights for improving the efficacy of prostate cancer treatment. read more here.
Keywords: inhibits prostate; progression via; pentamidine inhibits; prostate cancer ... See more keywords